Market Insights
"The single-use systems market is likely to grow at an exceptional CAGR of 16.3% during 2024-2030 to reach USD 17 billion in 2030".
Want to know more about the market scope? Register Here
Market Dynamics
Introduction
Single-use systems for bioprocess solutions refer to the use of disposable, or single-use, components in the manufacturing and processing of biopharmaceuticals. Single-use technologies offer several advantages in terms of flexibility, cost-effectiveness, and reduced risk of cross-contamination. These solutions allow for more flexible and scalable manufacturing processes. As a result, biopharmaceutical companies can easily adjust their production capacities based on demand without the need for extensive facility modifications.
Single-Use Systems Market Report Overview
|
Market Size in 2030
|
USD 17 billion
|
Market Growth (2024-2030)
|
16.3% CAGR
|
Base Year of Study
|
2023
|
Trend Period
|
2018-2022
|
Forecast Period
|
2024-2030
|
Market Drivers
In recent years, the biopharmaceutical industry has witnessed significant growth, driven by factors such as the increasing prevalence of chronic diseases, advancements in biotechnology, and a growing aging population. Continuous advancements in bioprocessing technologies, including single-use systems, have played a crucial role in enhancing efficiency, reducing costs, and improving flexibility in biopharmaceutical manufacturing. Single-use bioprocessing systems have gained popularity due to their advantages, such as reduced contamination risk, faster turnaround times, and lower capital expenditures compared to traditional stainless-steel systems. These technologies also offer greater flexibility and scalability, allowing biopharmaceutical companies to adapt quickly to the changing market demands and scale production as needed.
In addition, the World Health Organization (WHO) has been increasingly supportive of single-use technologies, provided that they meet the required quality and safety standards. This has encouraged more companies to adopt single-use systems in their biopharmaceutical processes.
Recent Developments:
- In April 2023, Merck KGaA announced the launch of its Ultimus single-use process container film, designed to provide extreme durability and leak resistance for single-use assemblies used for bioprocessing liquid applications.
- In March 2020, Thermo Fisher Scientific Inc. invested over US$ 475 million to enhance biologics development, manufacturing, and cell and gene therapy capabilities at its St. Louis site in Missouri. In addition, the site completed its expansion, doubling its single-use production capacity for biological drug substance development and commercial manufacturing.
Merger & Acquisitions: In recent years, there have been a fair number of strategic alliances, including M&As, JVs, etc., in the biopharmaceutical industry across the globe. Some of them have been mentioned below:
- In July 2023, Sartorius AG completed the acquisition of the French company Polyplus, a leading provider of innovative technologies for cell and gene therapies.
- In March 2020, Danaher Corporation completed the acquisition of the GE biopharma business.
Segment Analysis
Segmentations
|
List of Sub-Segments
|
Dominant and Fastest-Growing Segments
|
Product-Type Analysis
|
Media Bags and Containers, Bioreactors, Tangential-Flow Filtration Devices, Depth Filters, Disposable Fiber Cartridges, Mixing Systems, Tubing Assemblies, Sampling Systems, and Others.
|
Media bags and containers are likely to be the dominant product category. Bioreactor is estimated to witness the fastest growth in the coming years.
|
Method-Type Analysis
|
Filtration, Cell Culture, Purification, Mixing, and Storage.
|
Filtration is anticipated to remain the dominant segment whereas purification is estimated to witness the fastest growth in the years to come.
|
Application-Type Analysis
|
Monoclonal Antibody Production, Vaccine Production, Plant Cell Cultivation, Patient Specific Cell Therapies, and Others.
|
Monoclonal antibody production is expected to remain the dominant segment whereas patient-specific cell therapies are estimated to be the fastest-growing segment
|
End-User Type Analysis
|
Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research, and Contract Research Organizations & Manufacturers.
|
Biopharmaceutical manufacturers are anticipated to remain the dominant category during the forecast period. Contract research organizations & manufacturers are likely to witness the fastest growth.
|
Regional Analysis
|
North America, Europe, China, Rest of Asia-Pacific, and The Rest of the World.
|
In the years ahead, Europe is anticipated to be the dominant market, while China is expected to emerge as the fastest-growing market.
|
By Product Type
"Single-use media bags and containers dominate the market during the forecast period".
- The market is segmented into media bags and containers, bioreactors, tangential-flow filtration devices, depth filters, disposable fiber cartridges, mixing systems, tubing assemblies, sampling systems, and others.
- Among these products, single-use media bags and containers dominate biopharmaceutical manufacturing, due to their flexibility, scalability, and cost-effectiveness, eliminating the need for cleaning and validation between batches while reducing the risk of cross-contamination.
By Method Type
"Filtration is expected to remain the dominant segment of the market throughout the forecast period".
- The market is segmented into filtration, cell culture, purification, mixing, and storage.
- Among these methods, filtration is expected to remain the dominant segment of the market throughout the forecast period, as it is a fundamental and widely used step in biopharmaceutical processing for separating impurities and particulate matter from the desired product. It is a crucial method for achieving high product purity.
By Application Type
" Monoclonal antibody production is expected to remain the dominant segment of the market in the coming years".
- The market is segmented into monoclonal antibody production, vaccine production, plant cell cultivation, patient-specific cell therapies, and others.
- Among these applications, monoclonal antibody production is expected to remain the dominant segment of the market in the coming years, as it plays a crucial role in treating various diseases, including cancer and autoimmune disorders, driving a high demand for their production.
By End-User Type
"Biopharmaceutical manufacturers are expected to remain the biggest demand generator in the market during the forecast period".
- The market is segmented into biopharmaceutical manufacturers, life science R&D companies & academic research, and contract research organizations & manufacturers.
- Among these end-users, biopharmaceutical manufacturers are expected to remain the biggest demand generator in the market during the forecast period. This is primarily owing to the increased flexibility, scalability, cost-efficiency, and reduced contamination risks offered by the single-use technologies, that completely align with the dynamic nature of biopharmaceutical production.
Regional Analysis
"Europe is expected to remain the largest market for single-use systems during the forecast period".
- Driven by stringent regulatory standards upheld by the European Medicines Agency (EMA), aligned with the adoption of single-use biopharma processing technologies for enhanced product quality and reduced cross-contamination risk.
"China is likely to witness the fastest growth in the market in the coming years".
- Due to the significant growth in the biopharmaceutical industry in this region, driven by factors, such as rising healthcare expenditure and the active presence of the major companies, such as Danaher Corporation, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc., in the region.
Know the high-growth countries in this report. Register Here
Key Players
The global market for single-use systems is very competitive and highly consolidated, with the leading companies capturing the lion’s market share. The major players compete on some of the governing factors including price, product offerings, regional presence, etc. The following are the key players in the single-use systems market.
- Sartorius AG
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Merck KGaA
Note: The above list does not necessarily include all the top players in the market.
Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market.
What Deliverables Will You Get in this Report?
Key questions this report answers
|
Relevant contents in the report
|
How big is the sales opportunity?
|
In-depth Analysis of the Single-Use Systems Market
|
How lucrative is the future?
|
Market forecast and trend data and emerging trends
|
Which regions offer the best sales opportunities?
|
Global, regional, and country-level historical data and forecasts
|
Which are the most attractive market segments?
|
Market Segment Analysis and Forecast
|
Which are the top players and their market positioning?
|
Competitive landscape analysis, Market share analysis
|
How complex is the business environment?
|
Porter’s five forces analysis, PEST analysis, Life cycle analysis
|
What are the factors affecting the market?
|
Drivers & challenges
|
Will I get the information on my specific requirements?
|
10% free customization
|
Research Methodology
- This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects today’s single-use systems market realities and future market possibilities for the forecast period.
- The report segments and analyzes the market in the most detailed manner to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.
- This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
- More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.
- We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
Report Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
- Detailed profiling of additional market players (up to three players)
- SWOT analysis of key players (up to three players)
Competitive Benchmarking
- Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.